H
Hans Duvekot
Researcher at Erasmus University Rotterdam
Publications - 28
Citations - 499
Hans Duvekot is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Pregnancy & Randomized controlled trial. The author has an hindex of 10, co-authored 27 publications receiving 436 citations. Previous affiliations of Hans Duvekot include University Medical Center Utrecht.
Papers
More filters
Journal ArticleDOI
Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): A multicentre, open-label randomised controlled trial
Sophie Liem,Ewoud Schuit,Maud A. Hegeman,Joke M.J. Bais,Karin de Boer,Kitty W.M. Bloemenkamp,Jozien T. J. Brons,Hans Duvekot,Bas Nij Bijvank,Maureen T.M. Franssen,Ingrid Gaugler,Irene M. de Graaf,Martijn A. Oudijk,Dimitri N.M. Papatsonis,Paula J.M. Pernet,Martina Porath,Liesbeth Scheepers,Marko Sikkema,Jan Sporken,Harry Visser,Wim van Wijngaarden,Mallory Woiski,Mariëlle G. van Pampus,Ben W.J. Mol,Dick J. Bekedam +24 more
TL;DR: In unselected women with a multiple pregnancy, prophylactic use of a cervical pessary does not reduce poor perinatal outcome.
Journal ArticleDOI
Perinatal outcome of monoamniotic twin pregnancies.
Karien E. A. Hack,Jan B. Derks,A.H.P. Schaap,Enrico Lopriore,Sjoerd G. Elias,Birgit Arabin,Alex J. Eggink,Krystyna M. Sollie,Ben W.J. Mol,Hans Duvekot,Christine Willekes,Attie T. J. I. Go,Corine Koopman-Esseboom,Frank P.H.A. Vandenbussche,Gerard H. A. Visser +14 more
TL;DR: In this paper, the authors studied perinatal mortality and neonatal morbidity in a large cohort of mono-amniotic twin pregnancies with special emphasis to the gestational age-specific mortality.
Journal ArticleDOI
Cervical Pessaries for Prevention of Preterm Birth in Women With a Multiple Pregnancy (ProTWIN): A Multicentre, Open-Label Randomized Controlled Trial
Sophie Liem,Ewoud Schuit,Maud A. Hegeman,Joke M.J. Bais,K. de Boer,K.W. Bloemenkamp,J.T.J. Brons,Hans Duvekot,Bas Nij Bijvank,Maureen T.M. Franssen,Ingrid Gaugler,I. M. de Graaf,M.A. Oudijk,D. N. M. Papatsonis,Paula Pernet,M. Porath,Liesbeth Scheepers,M.J. Sikkema,Jan Sporken,H. Visser,W. van Wijngaarden,Mallory Woiski,M.G. van Pampus,B. W. J. Mol,Dick J. Bekedam +24 more
TL;DR: This multicenter, open-label, randomized controlled trial involving 40 hospitals was undertaken to determine whether a cervical pessary could prevent poor perinatal outcomes in women with a multiple pregnancy.
Journal ArticleDOI
Cervical Pessaries for Prevention of Preterm Birth in Women With a Multiple Pregnancy (ProTWIN): A Multicentre, Open-label Randomised Controlled Trial
Sophie Liem,Ewoud Schuit,Maud A. Hegeman,Joke M.J. Bais,Karin de Boer,Kitty W.M. Bloemenkamp,Jozien T. J. Brons,Hans Duvekot,Bas Nij Bijvank,Maureen T.M. Franssen,Ingrid Gaugler,Irene M. de Graaf,Martijn A. Oudijk,Dimitri N.M. Papatsonis,Paula J.M. Pernet,Martina Porath,Liesbeth Scheepers,Marko Sikkema,Jan Sporken,Harry Visser,Wim van Wijngaarden,Mallory Woiski,Mariëlle G. van Pampus,Ben W.J. Mol,Dick J. Bekedam +24 more
TL;DR: A composite of poor perinatal outcomes, including stillbirth, preventricular leukomalacia, severe respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, and neonatal death within 6 weeks after the anticipated term date was performed.
Journal ArticleDOI
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour : APOSTEL III-Trial)
Elvira O.G. van Vliet,Ewoud Schuit,Karst Y. Heida,Brent C. Opmeer,Marjolein Kok,Wilfried Gyselaers,Martina Porath,Mallory Woiski,Caroline J. Bax,Kitty W.M. Bloemenkamp,Hubertina C.J. Scheepers,Yves Jaquemyn,Erik van Beek,Hans Duvekot,Maureen T.M. Franssen,Bas Nij Bijvank,Joke H. Kok,Arie Franx,Ben W.J. Mol,Martijn A. Oudijk +19 more
TL;DR: This multicenter randomised clinical trial aims to compare nifedipine and atosiban in terms of neonatal outcome, duration of pregnancy and maternal side effects, and provide evidence on the optimal drug of choice in acute tocolysis in threatening preterm labour.